From: Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma
Marker
Hazard Ratio
95% CI
P
Sex
1.013
0.46–2.19
0.973
Age
1.011
0.98–1.04
0.480
AJCC Stage (I-III)
2.907
1.24–6.81
0.014
CMC status (0–1 vs ≥2 positive assays)
2.468
1.12–6.23
0.037